$EDSA rapid declines in vaccine efficacy, increasing distrust of Gov and big Pharma, increasing public resistance to the booster. Its looking like a nasty wave this winter and that Covid is most likely endemic. it should be clear to everyone that therapeutics and preventing serious Covid are needed more than ever. I am pro vax but vaccines alone are not sufficient. The door is very much still open for Edesa for the critically ill but they need to move with urgency. I don’t believe buyout talks are underway, but of course no one knows for sure. I think it’s too early. This all comes down to how fast they can deliver the rest of phrase 3. Par, we need assurances on urgency, p3 trial design, FDA responses and enrolment updates. Read the comments from other loyal investors running out of patience. I won’t sell but many will if you don’t engage shareholders better.
7
5
5 Likes